Literature DB >> 10196140

Interaction of human macrophage C-type lectin with O-linked N-acetylgalactosamine residues on mucin glycopeptides.

S Iida1, K Yamamoto, T Irimura.   

Abstract

A fluorescein-labeled synthetic peptide, PTTTPITTTTK, was converted into O-glycosylated glycopeptides with various numbers of attached N-acetyl-D-galactosamines (GalNAcs) by in vitro glycosylation with UDP-GalNAc and a microsomal fraction of LS174T human colon carcinoma cells. Glycopeptides with 1, 3, 5, and 6 GalNAc residues (G1, G3, G5, and G6) were obtained, and their sizes were confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Their sequences were determined by a peptide sequencer to be PTTTGalNAcPITTTTK for G1, PTGalNAcTTPITGalNAcTGalNAcTTK for G3, PTTGalNAcTGalNAcPITGalNAcTGalNAcTGalNAcTK for G5, and PTGalNAcTGalNAcTGalNAcPITGalNAcTGalNAcTGalNAcTK for G6. A calcium-type human macrophage lectin (HML) was prepared in a recombinant form, and its interaction with these glycopeptides was investigated by surface plasmon resonance (SPR) spectroscopy and fluorescence polarization. The affinity of recombinant HML (rHML) for immobilized glycopeptides increased, as revealed by SPR, in parallel with the number of GalNAc. The highest affinity was obtained when the G6-peptide was immobilized at high density. Fluorescence polarization equilibrium-binding assays also revealed that the affinity of rHML for soluble gly-copeptides increased, depending on the number of attached GalNAcs. Carbohydrate recognition domain (CRD) fragments of HML were prepared, and their affinity for these four glycopeptides was also determined, this affinity was apparently lower than that of rHML. Affinity constants of rHML for the G3- and G5-peptides were 11- and 38-fold higher, respectively, than for the G1-peptide, whereas those of CRD fragments were only 2- and 6-fold higher, respectively. A chemical cross-linking study revealed that rHML but not recombinant CRD forms trimers in an aqueous solution. Thus, preferential binding of densely glycosylated O-linked glycopeptides should be due to the trimer formation of rHML.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196140     DOI: 10.1074/jbc.274.16.10697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.

Authors:  S André; B Frisch; H Kaltner; D L Desouza; F Schuber; H J Gabius
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.

Authors:  Filipa Marcelo; Nitin Supekar; Francisco Corzana; Joost C van der Horst; Ilona M Vuist; David Live; Geert-Jan P H Boons; David F Smith; Sandra J van Vliet
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  Carbohydrate specificity of an insecticidal lectin isolated from the leaves of Glechoma hederacea (ground ivy) towards mammalian glycoconjugates.

Authors:  Tanuja Singh; June H Wu; Willy J Peumans; Pierre Rougé; Els J M Van Damme; Richard A Alvarez; Ola Blixt; Albert M Wu
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.

Authors:  Chanel Tyler; Arvinder Kapur; Mildred Felder; Jennifer A Belisle; Christine Trautman; Jennifer A A Gubbels; Joseph P Connor; Manish S Patankar
Journal:  Am J Reprod Immunol       Date:  2012-03-01       Impact factor: 3.886

5.  Order and maximum incorporation of N-acetyl-D-galactosamine into threonine residues of MUC2 core peptide with microsome fraction of human-colon-carcinoma LS174T cells.

Authors:  S Iida; H Takeuchi; K Kato; K Yamamoto; T Irimura
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

6.  Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.

Authors:  Akira Konno; Yutaka Hoshino; Shinya Terashima; Ryoichi Motoki; Takanori Kawaguchi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 7.  Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

Authors:  Tongzhong Ju; Yingchun Wang; Rajindra P Aryal; Sylvain D Lehoux; Xiaokun Ding; Matthew R Kudelka; Christopher Cutler; Junwei Zeng; Jianmei Wang; Xiaodong Sun; Jamie Heimburg-Molinaro; David F Smith; Richard D Cummings
Journal:  Proteomics Clin Appl       Date:  2013-09-09       Impact factor: 3.494

8.  Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells.

Authors:  Kaori Denda-Nagai; Satoshi Aida; Kengo Saba; Kiwamu Suzuki; Saya Moriyama; Sarawut Oo-Puthinan; Makoto Tsuiji; Akiko Morikawa; Yosuke Kumamoto; Daisuke Sugiura; Akihiko Kudo; Yoshihiro Akimoto; Hayato Kawakami; Nicolai V Bovin; Tatsuro Irimura
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

9.  Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.

Authors:  Karien Bloem; Ilona M Vuist; Arend-Jan van der Plas; Léon M J Knippels; Johan Garssen; Juan J García-Vallejo; Sandra J van Vliet; Yvette van Kooyk
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin.

Authors:  Donella M Beckwith; Forrest G FitzGerald; Maria C Rodriguez Benavente; Elizabeth R Mercer; Anna-Kristin Ludwig; Malwina Michalak; Herbert Kaltner; Jürgen Kopitz; Hans-Joachim Gabius; Maré Cudic
Journal:  Biochemistry       Date:  2021-02-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.